ad

Shree Ganesh Remedies Q2 Results FY27: Profit Falls 67.14% YoY, Revenue Rs 23.30 Cr, PAT Rs 1.63 Cr

31 Oct 2026 • 7:40 pm

Shree Ganesh Remedies Q2 Results FY27: Profit Falls 67.14% YoY, Revenue Rs 23.30 Cr, PAT Rs 1.63 Cr

Quick Answer

Shree Ganesh Remedies Q2 Results FY27 were declared on 31 October 2026. The quarterly results show revenue of Rs 23.30 Cr, down 23.15% YoY from Rs 30.32 Cr, and net profit of Rs 1.63 Cr, down 67.14% YoY from Rs 4.96 Cr. YoY growth is negative on both lines, while both figures are higher than the previous quarter.

Shree Ganesh Remedies Ltd (SGRL) Q2 Results FY27 announced on 31 October 2026, covering the company's financial performance for the July to September quarter. Revenue stood at Rs 23.30 Cr against Rs 30.32 Cr a year earlier, while PAT came in at Rs 1.63 Cr against Rs 4.96 Cr. Shree Ganesh Remedies Q2 Results FY27 therefore show a YoY decline on both lines. The results date, 31 October 2026, anchors every comparison that follows.

This Shree Ganesh Remedies Q2 Results analysis covers the financial highlights, business drivers, outlook and risks behind the numbers. Readers can pair this results analysis with the Univest Screener to follow the stock. The financial highlights come first.

Click Here – Get Free Investment Predictions

Shree Ganesh Remedies Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 23.3 Cr Rs 30.32 Cr -23.15% YoY
Net Profit (PAT) Rs 1.63 Cr Rs 4.96 Cr -67.14% YoY

Source: company filing for Shree Ganesh Remedies Q2 Results FY27, 31 October 2026. Figures in Rs Crore.

Key Takeaways from Shree Ganesh Remedies Q2 Results: What Stands Out

  • Revenue fell 23.15% YoY to Rs 23.30 Cr from Rs 30.32 Cr in the same quarter last year, a clear contraction on the top line.
  • Net profit fell 67.14% YoY to Rs 1.63 Cr from Rs 4.96 Cr, a steeper drop than revenue in Shree Ganesh Remedies Q2 Results FY27.
  • Revenue rose 62.3% quarter on quarter from Rs 14.36 Cr, even as YoY growth stayed negative against the year-ago quarter.
  • Net profit rose 45.5% quarter on quarter from Rs 1.12 Cr, while net profit margin narrowed to 7.0% from 16.4% a year earlier.
  • Quarterly net profit has been volatile, a point the performance analysis examines next.

Shree Ganesh Remedies Q2 Results FY27: Performance Analysis

Shree Ganesh Remedies Q2 Results FY27 show a YoY decline on both the top line and the bottom line. Revenue fell 23.15% to Rs 23.30 Cr from Rs 30.32 Cr, while net profit fell 67.14% to Rs 1.63 Cr from Rs 4.96 Cr. Profit therefore contracted more than twice as fast as revenue.

The sequential view adds context to Shree Ganesh Remedies Q2 Results. Revenue rose 62.3% from Rs 14.36 Cr in the previous quarter and net profit rose 45.5% from Rs 1.12 Cr, so the quarterly results sit above the prior quarter but below the year-ago level. The results analysis also shows net profit margin of 7.0% against 16.4% in the comparison quarter.

Investors tracking the YoY growth trend will watch whether revenue and net profit hold above the previous quarter in later disclosures. Shree Ganesh Remedies Q2 Results FY27 give one data point, and subsequent filings will show whether it forms a pattern. That brings the results analysis to the business factors behind the quarter.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Quarter on Quarter Revenue Rise – The results analysis points to a 62.3% sequential increase in revenue, from Rs 14.36 Cr to Rs 23.30 Cr. The supplied data confirms the rise in these quarterly results but does not establish the specific cause behind it.

Quarter on Quarter Net Profit Rise – Net profit rose 45.5% from Rs 1.12 Cr to Rs 1.63 Cr, a smaller percentage gain than revenue, which shaped Shree Ganesh Remedies Q2 Results FY27 as a sequential rise within a wider YoY decline.

Net Profit Margin Comparison – Net profit margin narrowed to 7.0% from 16.4% in the comparison quarter, so each rupee of revenue converted into less net profit than a year earlier. This is why net profit fell faster than revenue on a YoY basis.

FY27 Outlook After Shree Ganesh Remedies Q2 Results

Full-year FY27 results for Shree Ganesh Remedies will depend on the quarters that follow and on conditions disclosed in later filings. Shree Ganesh Remedies Q2 Results FY27 form one data point of the year, and net profit in the coming quarters will show how the year builds from here.

Readers can follow later filings on the Univest Screener and compare each new quarter with the Rs 23.30 Cr revenue and Rs 1.63 Cr net profit reported here. Each results analysis should start from that base, which makes the risks in the quarterly results the next topic to examine.

Key Risks to Watch After Shree Ganesh Remedies Q2 Results FY27

Revenue Decline Year on Year

Revenue declined 23.2% year on year to Rs 23.30 Cr in the latest quarter. Shree Ganesh Remedies Q2 Results FY27 therefore show a lower top line than the Rs 30.32 Cr reported a year earlier, which is the first risk to monitor.

Net Profit Decline

Net profit fell 67.1% year on year to Rs 1.63 Cr from Rs 4.96 Cr. The negative YoY growth in profit is larger than in revenue, so the margin trend matters for later quarters.

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 1.12 Cr to Rs 6.27 Cr over the last 5 quarters. Such a wide range means any single quarter should be read alongside the others.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Shree Ganesh Remedies Q2 Results FY27 show revenue of Rs 23.30 Cr and net profit of Rs 1.63 Cr, both lower YoY but higher than the previous quarter. The quarterly results therefore point to a mixed picture across the two comparisons. For Univest readers, Shree Ganesh Remedies Q2 Results are best read alongside later filings. Investors should consult a SEBI-registered advisor before acting on any information here.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Shree Ganesh Remedies Q2 Results FY27

What are Shree Ganesh Remedies Q2 Results FY27?

Ans. Shree Ganesh Remedies Q2 Results FY27 cover the July to September 2026 quarter and show revenue of Rs 23.30 Cr and net profit of Rs 1.63 Cr, while the Quick Answer at the top summarises both figures.

What is the results date for Shree Ganesh Remedies Q2 Results FY27?

Ans. Shree Ganesh Remedies declared its Q2 results on 31 October 2026, so this results date anchors the comparison, while the introduction explains how each figure relates to the same filing.

What revenue was reported in Shree Ganesh Remedies Q2 Results FY27?

Ans. Shree Ganesh Remedies reported revenue of Rs 23.30 Cr in the quarter, compared with Rs 30.32 Cr a year earlier, as the Financial Highlights table and Performance Analysis both show.

What net profit was reported in Shree Ganesh Remedies Q2 Results FY27?

Ans. Net profit came in at Rs 1.63 Cr for the quarter, compared with Rs 4.96 Cr in the same quarter last year, which the Performance Analysis section places in context.

How much YoY growth did revenue show in Shree Ganesh Remedies Q2 Results FY27?

Ans. Revenue showed negative YoY growth of 23.15%, falling to Rs 23.30 Cr from Rs 30.32 Cr, while the Key Takeaways section lists this alongside the sequential revenue rise of 62.3%.

Did net profit rise or fall in Shree Ganesh Remedies Q2 Results?

Ans. Shree Ganesh Remedies Q2 Results show net profit falling 67.14% YoY to Rs 1.63 Cr, although it rose 45.5% from the previous quarter, as the Performance Analysis section explains.

How does quarter on quarter revenue compare in Shree Ganesh Remedies Q2 Results FY27?

Ans. Revenue rose 62.3% from Rs 14.36 Cr in the previous quarter to Rs 23.30 Cr, which means the YoY decline sits against a higher sequential base, as the Key Business Factors section notes.

What was the net profit margin in Shree Ganesh Remedies Q2 Results FY27?

Ans. Net profit margin was 7.0% in the quarter, compared with 16.4% in the comparison quarter, so the margin narrowed, a point covered under Key Business Factors.

What business factors shaped Shree Ganesh Remedies Q2 Results FY27?

Ans. The supplied factors are a 62.3% sequential revenue rise, a 45.5% sequential net profit rise and a narrower net profit margin, all of which the Key Business Factors section describes in detail.

What are the key risks after Shree Ganesh Remedies Q2 Results FY27?

Ans. The listed risks are the 23.2% YoY revenue decline, the 67.1% YoY net profit fall and volatile quarterly net profit, which the Key Risks section covers in detail.

What is the outlook after Shree Ganesh Remedies Q2 Results?

Ans. Full-year FY27 results for Shree Ganesh Remedies will depend on the quarters that follow, so later filings will show whether this quarter forms a pattern, as the Outlook section explains.

Where can I find the complete Shree Ganesh Remedies Q2 Results FY27 data?

Ans. The Financial Highlights table in this article lists the revenue and net profit comparison, while the Univest Screener lets readers follow later filings for Shree Ganesh Remedies.


Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5
ad

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited

Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003

Write to us : support@univest.in, compliance@univest.in

Verify on SEBI registry →

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down